BSP Medical is a ground-breaking biomedical technology company, revolutionizing non-invasive diagnosis of cardiac diseases. The company was founded by seasoned researchers in the field of high frequency ECG analysis. We are devoted to the HyperQ technology and promoting its clinical implementation in an effort to provide superior patient care. We are a wholly owned subsidiary of Israel China Biotechnology (ICB) Ltd. which is publicly traded on the Tel Aviv Stock Exchange. Together with CIB, China-Israel Biological Technology Co., Ltd, we funded two joint ventures (JV) in China, which are responsible for localization and commercialization of our product in the greater China market. The Chairman of the Board of Directors of CIB and ICB is Mr. Qingxi Huang, a prominent investor with a large portfolio of medical technology companies.